- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Antibiotic treatment duration not associated with UTI recurrence in children
USA: Consistent with antimicrobial stewardship efforts, a recent study has found that the duration of antibiotic treatment for uncomplicated urinary tract infection (UTI) is not significantly associated with UTI recurrence in pediatric patients. The findings, published in the Annals of Pharmacotherapy, provide support for shorter-course treatment.
Inconsistencies and gaps in published information about optimal antibiotic treatment duration for uncomplicated UTI in pediatric patients pose a dilemma for antibiotic stewardship. To address this, Titilola M. Afolabi, Midwestern University, Glendale, AZ, USA, and colleagues conducted the study to evaluate the association of antibiotic treatment duration with recurrence rates in children with new-onset cystitis or pyelonephritis.
For the purpose, the authors used the Truven Health MarketScan Database (2013-2015) to obtain data on patients aged 2-17 years with new-onset cystitis or pyelonephritis not caused by a renal or anatomical abnormality.
Key findings of the study include:
· Of 7698 patients, 85.5% had cystitis, 14.3% pyelonephritis.
· Duration of antibiotic treatment was as follows: 3 to 5 days for cystitis (20.4%) or 7 (33.6%), 10 (44.2%), or 14 (1.8%) days for any UTI.
· Recurrence occurred in 5.5% of patients.
· Covariates associated with increased recurrence risk included pretreatment antibiotic exposure (odds ratio [OR] = 1.29), pyelonephritis on diagnosis date (OR = 1.44), follow-up visit during antibiotic treatment (OR = 3.21), parenteral antibiotic (OR = 1.89), and interaction of pyelonephritis diagnosis with nitrofurantoin monotherapy (OR = 3.68).
· After adjustment for covariates, the association between the duration of antibiotic treatment and recurrence was not significant (compared with 7 days: 10 days: OR = 1.07; 14 days: OR = 0.89).
"This lack of a significant difference among the measured antibiotic treatment durations lends support to a shortened duration of 7 days of antibiotic therapy as a suitable option for uncomplicated UTI in children aged 2 to 17 years, adding to the currently available base of evidence to guide treatment duration decisions for pediatric UTI," concluded the authors.
The study, "Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients," is published in the journal Annals of Pharmacotherapy.
DOI: https://doi.org/10.1177/1060028019900650
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751